Are Options Traders Bullish on AKAO?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

About AKAO

AKAO is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of antibacterials to treat MDR gram-negative infections. Achaogen is developing plazomicin, Achaogen's lead product candidate, for the treatment of serious lung, bloodstream, and urinary tract infections due to Enterobacteriaceae, including CRE. Achaogen's plazomicin program is funded in part with a contract from the Biomedical Advanced Research and Development Authority. Plazomicin is the first clinical candidate from Achaogen's gram-negative antibiotic discovery engine, and Achaogen has other programs in early and late preclinical stages focused on other MDR gram-negative infections.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

AKAO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
EQWS Invesco Russell 2000 Equal Weight ETF 20.0 M 2E+07 1,952 1952 0.02% 0.00022 4 K 4300
ITOT iShares Core S&P Total U.S. Stock Market ETF 16.5 B 1.65381E+10 3,387 3387 0.0% 0 28 K 27962
IWC iShares Microcap ETF 914.3 M 9.14298E+08 1,459 1459 0.01% 0.0001 105 K 105478
IWM iShares Russell 2000 ETF 41.5 B 4.15155E+10 2,023 2023 0.0% 0 820 K 819598
IWN iShares Russell 2000 Value ETF 9.3 B 9.26904E+09 1,381 1381 0.0% 0 50 K 49851
IWO iShares Russell 2000 Growth ETF 8.9 B 8.86114E+09 1,249 1249 0.0% 0 327 K 327329
IWV iShares Russell 3000 ETF 9.5 B 9.52999E+09 2,990 2990 0.0% 0 13 K 13380
URTY ProShares UltraPro Russell2000 114.2 M 1.14192E+08 2,034 2034 0.0% 3.70327E-06 1 K 1436
UWM ProShares Ultra Russell2000 163.2 M 1.6324E+08 2,034 2034 0.0% 7.75862E-06 3 K 2768

Wait, Before You Leave...